Enterome to Attend the Jefferies 2018 Global Healthcare Conference in New York

PARIS and CAMBRIDGE, Ma., June 4, 2018 /PRNewswire/ -- Enterome SA, a clinical-stage biotechnology company pioneering innovative therapies to treat microbiome-associated diseases with a focus on inflammatory bowel diseases (IBD) and immuno-oncology (IO) indications, will attend the...

from PR Newswire: //https://ift.tt/2xFQPPv